Literature DB >> 14656022

New basis of the neurotrophic action of vitamin B12.

Giuseppe Scalabrino1, Francesca R Buccellato, Daniela Veber, Elena Mutti.   

Abstract

Over the last few years we have reproduced all of the key morphological and biochemical features of human subacute combined degeneration in the central nervous system and peripheral nervous system of rats made cobalamin-deficient by means of total gastrectomy or a chronic cobalamin-deficient diet. We have also recently clarified the pathogenesis of experimental subacute combined degeneration induced in the rat by cobalamin deprivation. The results of our studies strongly support the notion that cobalamin plays a pivotal role in regulating the balance of the network of cytokines and growth factors in the central nervous system of the rat. We have demonstrated that cobalamin tightly regulates the central nervous system synthesis and/or the cerebrospinal fluid level of two cytokines, tumor necrosis factor-alpha and interleukin-6, and a growth factor, epidermal growth factor. Of these neuroactive agents, one, tumor necrosis factor-alpha, is neurotoxic, whereas the others are neurotrophic. Therefore, it becomes clear that cobalamin-deficient central neuropathy is caused not by the withdrawal of the vitamin, but reflects a locally increased production of neurotoxic agents, combined with the locally decreased production of neurotrophic agents.

Entities:  

Mesh:

Year:  2003        PMID: 14656022     DOI: 10.1515/CCLM.2003.220

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  Vitamine-B12-deficiency causing isolated and partially reversible leukoencephalopathy.

Authors:  Magnus-Sebastian Vry; Katharina Haerter; Oliver Kastrup; Elke Gizewski; Markus Frings; Matthias Maschke
Journal:  J Neurol       Date:  2005-06-13       Impact factor: 4.849

Review 2.  Interrelationships of undernutrition and neurotoxicity: food for thought and research attention.

Authors:  Peter S Spencer; Valerie S Palmer
Journal:  Neurotoxicology       Date:  2012-02-28       Impact factor: 4.294

Review 3.  A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis.

Authors:  Matin Khosravi-Largani; Parmida Pourvali-Talatappeh; Ali Mohammad Rousta; Maedeh Karimi-Kivi; Elahe Noroozi; Ali Mahjoob; Yasaman Asaadi; Alireza Shahmohammadi; Sarina Sadeghi; Shiva Shakeri; Kimiya Ghiyasvand; Masoumeh Tavakoli-Yaraki
Journal:  eNeurologicalSci       Date:  2018-01-28

Review 4.  The Many Faces of Cobalamin (Vitamin B12) Deficiency.

Authors:  Bruce H R Wolffenbuttel; Hanneke J C M Wouters; M Rebecca Heiner-Fokkema; Melanie M van der Klauw
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27

5.  Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases.

Authors:  Jeremias Motte; Janina Kneiphof; Katrin Straßburger-Krogias; Kalliopi Pitarokoili; Anna Lena Fisse; Ludwig Kappos; Ralf Gold
Journal:  Ther Adv Neurol Disord       Date:  2019-08-24       Impact factor: 6.570

Review 6.  The Role of Neurotropic B Vitamins in Nerve Regeneration.

Authors:  Simone Baltrusch
Journal:  Biomed Res Int       Date:  2021-07-13       Impact factor: 3.411

7.  Modulation of vigabatrin induced cerebellar injury: the role of caspase-3 and RIPK1/RIPK3-regulated cell death pathways.

Authors:  Marwa Abd El-Kader; Eman Hamza; Randa El-Gamal; Amira Sobhy Rashed Eladl; Eman Mohamad El Nashar; Mansour A Alghamdi; Omnia S Erfan
Journal:  J Mol Histol       Date:  2021-05-27       Impact factor: 2.611

Review 8.  Novel insights into the effect of vitamin B₁₂ and omega-3 fatty acids on brain function.

Authors:  Richa Rathod; Anvita Kale; Sadhana Joshi
Journal:  J Biomed Sci       Date:  2016-01-25       Impact factor: 8.410

9.  A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy.

Authors:  Amrita Sil; Hrishikesh Kumar; Rahul Deb Mondal; Sidharth Sankar Anand; Anirban Ghosal; Ashis Datta; Sandesh V Sawant; Vaibhavi Kapatkar; Ganesh Kadhe; Sameer Rao
Journal:  Korean J Pain       Date:  2018-07-02

10.  Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Subacute Combined Degeneration: Revealing a Genetic Predisposition.

Authors:  Xin Zhang; Chen Hou; Peng Liu; Li Chen; Yue Liu; Peng Tang; Rui Li
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.